S. 3712: Baby Observation Act
The bill known as the Baby Observation Act focuses on the study and evaluation of home cardiorespiratory monitors for infants. The primary goal is to assess the effectiveness of these devices in preventing sudden unexpected infant death (SUID). Here are the main components of the bill:
Study on Home Cardiorespiratory Monitors
The Secretary of Health and Human Services is tasked with conducting a study that examines the use of home cardiorespiratory monitors. These monitors track vital signs such as heart rate and blood oxygen levels in infants. The study will particularly consider infants who are deemed high-risk for health issues.
Report Requirements
Within one year of the bill's enactment, the Secretary is required to submit a report to Congress containing:
- Evidence of Effectiveness: Information on how well these monitors work, including their performance and accuracy.
- New Models of Care: Suggestions for enhancing the infant's home sleeping environment using these monitors.
- Health Care Plan Criteria: Recommendations for what health care plans should consider appropriate coverage for these monitors.
- Product Efficacy Recommendations: Guidance on whether these monitors provide enough benefit to warrant coverage under public or private health insurance plans.
Overall Purpose
The overall purpose of the Baby Observation Act is to gather data and provide insights that could inform health care practices and policies regarding the use of home monitoring for infants, ultimately aiming to enhance infant safety and health outcomes.
Relevant Companies
- AMGN (Amgen Inc.): As a biopharmaceutical company, Amgen may be involved in research or production of medical devices, including monitors for infants, which could be influenced by findings from this legislation.
- ISRG (Intuitive Surgical, Inc.): Known for its medical devices, the company might have an interest in developing or improving technologies related to infant monitoring.
- MDT (Medtronic plc): Medtronic specializes in medical technology and could potentially be impacted by new regulations or guidelines regarding home monitoring devices.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
5 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Jan. 28, 2026 | Introduced in Senate |
| Jan. 28, 2026 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
